The costs of treating rheumatoid arthritis patients with complementary medicine: exploring the issue
Complementary Therapies in MedicinePublished 1 December 1999
Robbert van Haselen, Nicholas Graves, S. Dahiha
Citations22
SJR quartileQ1
SJR score1.02
SNIP1.32
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Understanding the marginal costs of providing complementary care to RA patients will inform the debate over whether these therapies are likely to be cost-effective and those who would like to explore the practicalities of establishing a service involving complementary medicine will gain an understanding of the likely provider costs.
Abstract
Understanding the marginal costs of providing complementary care to RA patients will inform the debate over whether these therapies are likely to be cost-effective. In addition, those who would like to explore the practicalities of establishing a service involving complementary medicine will gain an understanding of the likely provider costs. The cost of complementary medicine appears to be most sensitive to the time spent with the patient by the doctor.
Keywords
Medicine
The LancetPrevalence and cost of alternative medicine in Australia
949 Citations1996A. H. MacLennan, David Wilson +1 more
The rates of use and types of alternative medicine and therapists used by this population in 1993, and correlations with other demographic and medical variables are assessed, show women were more likely to consult naturopaths, iridiologists, and reflexologists than men.
BMJMethods in health services research: Interpreting the evidence: choosing between randomised and non-randomised studies
397 Citations1999Martin McKee, Annie Britton +4 more
A brief summary of a more detailed review of the impact of potential threats to validity of evaluative research and possible solutions.
BMJUnderstanding controlled trials: What is a patient preference trial?
297 Citations1998David Torgerson, Bonnie Sibbald
There may be a treatment effect which results from patient preferences and not from therapeutic efficacy, as participants may not be representative and patients receiving their preferred treatment may comply better than average.
PubMedLongterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone.
287 Citations1992Theodore Pincus, Samuel Marcum +1 more
Estimated drug continuation did not differ significantly according to age, duration of disease, or whether the drug was the first, second, or 3rd 2nd line drug used, but most courses were not continued beyond 2 years.
Lara D. VeekenTHE COST OF RHEUMATOID ARTHRITIS
170 Citations1996Emma McIntosh
This paper uses the Cost of Illness (COI) framework to estimate the cost of rheumatoid arthritis (RA) to society in the year 1992-93, showing that prevalence is three times higher amongst women than men.
British Journal of Clinical PharmacologyHomoeopathic therapy in rheumatoid arthritis: evaluation by double‐ blind clinical therapeutic trial.
162 Citations1980R.G. Gibson, S Gibson +2 more
There was a significant improvement in subjective pain, articular index, stiffness and grip strength in those patients receiving homoeopathic remedies whereas there was no significant change in the patients who received placebo.
PubMedAlternative medicine use by rheumatology patients in a universal health care setting.
136 Citations1994Michel Boisset, Mary‐Ann Fitzcharles
The results demonstrate a moderate use of alternative medicine by rheumatology patients, mostly inexpensive products and no cost spiritual aids.
British Journal of Clinical PharmacologySalicylates and homoeopathy in rheumatoid arthritis: preliminary observations.
55 Citations1978R.G. Gibson, Gibson Sl +4 more
This paper reports the results of a pilot study in which 41 patients with rheumatoid arthritis were treated with high doses of salicylate, 3.9 g per day, and the results compared with a further 54 similar patients treated with homoeopathy, which found the patients who received homoeopathic treatment did better than those who received salicYLate.
Aktuelle RheumatologieWirksamkeitsnachweis eines Homöopathikums bei chronischer Polyarthritis - Eine randomisierte Doppelblindstudie bei niedergelassenen Ärzten
25 Citations1991M. Wiesenauer, Wilhelm Gaus
BMJCommissioning complementary medicine
17 Citations1995Iain Smith
The opportunities presented to commissioning health authorities to decide what health care to purchase for local people has also provided an opportunity to rethink old prejudices, which have relaxed its attitude toward complementary medicine over the past decade.